March 27, 2026

ACSM Revises Resistance Training Guidance

Synthesized evidence clarifies which training variables enhance strength, hypertrophy, and performance.

Conexiant

March 26, 2026

Ultrasound Models Estimate Whole-Body Muscle Mass

New equations incorporating cross-sectional area improve estimation accuracy.

Conexiant

March 20, 2026

Obesity Care Lags Behind Advances in Treatment

A 2026 expert perspective highlights system-level gaps in care delivery

Conexiant

March 19, 2026

Wegovy HD Secures FDA Approval

Semaglutide 7.2 mg achieved 20.7% mean weight loss in STEP UP trials.

Conexiant

March 18, 2026

Exercise in a Pill Is Now in Human Trials

Atrogi's ATR-258 just dosed its first subjects — and the muscle data it's hunting could reframe how we treat weight loss.

Conexiant

March 17, 2026

Vitamin D Deficiency and Bone Disease

Review finds limited evidence that common vitamin D deficiency cutoffs consistently reflect bone disease risk in community dwellers

Conexiant

March 17, 2026

Obesity Medications Get New Guidance

Panel outlines pharmacotherapy roles across obesity complications and long-term weight management.

Conexiant

March 17, 2026

Comorbidities Worsen Carpal Tunnel Outcomes

Patients with systemic diseases had worse symptoms and function before and following surgery, though improvement after release was similar.

Conexiant

March 06, 2026

Weighted Vest in Obesity Trial

Daily standing and stepping time appeared to modify hip bone responses during dietary weight loss in a randomized trial

Conexiant

April 01, 2025

FDA Approves Freeze-Dried Jynneos Vaccine

Bavarian Nordic’s freeze-dried Jynneos vaccine offers logistical advantages over the liquid-frozen version, supporting long-term U.S. stockpiling and public health preparedness.

Conexiant